Invivyd Stock Performance
| IVVD Stock | USD 0.59 0.08 11.94% |
The company retains a Market Volatility (i.e., Beta) of 3.31, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Invivyd will likely underperform. At this point, Invivyd has a negative expected return of -0.42%. Please make sure to check out Invivyd's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Invivyd performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Invivyd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
1 | Invivyd at the Ready for Upcoming Respiratory Virus Season with PEMGARDA to Help Protect Vulnerable Immunocompromised Persons from COVID-19 | 09/12/2024 |
2 | Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA | 09/23/2024 |
3 | Invivyd Announces U.S. FDA Has Updated the PEMGARDA EUA Fact Sheet with Accurate SARS-CoV-2 Variant Susceptibility and PEMGARDA Activity Data | 10/01/2024 |
4 | Invivyd to Present PEMGARDA Data at Infectious Disease Week 2024 | 10/16/2024 |
5 | Invivyds Buy Rating Reiterated at HC Wainwright | 11/01/2024 |
6 | Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, a... | 11/12/2024 |
7 | FMR LLCs Strategic Reduction in Invivyd Inc Shares | 11/13/2024 |
8 | Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA Emergency Use Authoriza... | 11/14/2024 |
9 | D. Boral Capital Reaffirms Buy Rating for Invivyd | 11/25/2024 |
| Begin Period Cash Flow | 92.1 M |
Invivyd |
Invivyd Relative Risk vs. Return Landscape
If you would invest 88.00 in Invivyd on August 29, 2024 and sell it today you would lose (29.00) from holding Invivyd or give up 32.95% of portfolio value over 90 days. Invivyd is currently does not generate positive expected returns and assumes 6.337% risk (volatility on return distribution) over the 90 days horizon. In different words, 56% of stocks are less volatile than Invivyd, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Invivyd Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Invivyd's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Invivyd, and traders can use it to determine the average amount a Invivyd's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0671
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IVVD |
Estimated Market Risk
| 6.34 actual daily | 56 56% of assets are less volatile |
Expected Return
| -0.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Invivyd is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Invivyd by adding Invivyd to a well-diversified portfolio.
Invivyd Fundamentals Growth
Invivyd Stock prices reflect investors' perceptions of the future prospects and financial health of Invivyd, and Invivyd fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Invivyd Stock performance.
| Return On Equity | -0.97 | ||||
| Return On Asset | -0.54 | ||||
| Operating Margin | (21.75) % | ||||
| Current Valuation | (34.66 M) | ||||
| Shares Outstanding | 119.62 M | ||||
| Price To Book | 0.85 X | ||||
| Price To Sales | 31.17 X | ||||
| EBITDA | (196.62 M) | ||||
| Net Income | (198.64 M) | ||||
| Cash And Equivalents | 418.67 M | ||||
| Cash Per Share | 3.84 X | ||||
| Total Debt | 2.17 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.14 X | ||||
| Book Value Per Share | 1.61 X | ||||
| Cash Flow From Operations | (173.16 M) | ||||
| Earnings Per Share | (1.95) X | ||||
| Market Capitalization | 70.57 M | ||||
| Total Asset | 229.18 M | ||||
| Retained Earnings | (732.07 M) | ||||
| Working Capital | 174.59 M | ||||
About Invivyd Performance
By analyzing Invivyd's fundamental ratios, stakeholders can gain valuable insights into Invivyd's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Invivyd has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Invivyd has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (283.47) | (297.64) | |
| Return On Tangible Assets | (0.87) | (0.91) | |
| Return On Capital Employed | (1.16) | (1.22) | |
| Return On Assets | (0.87) | (0.91) | |
| Return On Equity | (1.12) | (1.06) |
Things to note about Invivyd performance evaluation
Checking the ongoing alerts about Invivyd for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Invivyd help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Invivyd generated a negative expected return over the last 90 days | |
| Invivyd has high historical volatility and very poor performance | |
| Invivyd has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (198.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Invivyd currently holds about 418.67 M in cash with (173.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Invivyd has a frail financial position based on the latest SEC disclosures | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: D. Boral Capital Reaffirms Buy Rating for Invivyd |
- Analyzing Invivyd's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Invivyd's stock is overvalued or undervalued compared to its peers.
- Examining Invivyd's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Invivyd's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Invivyd's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Invivyd's stock. These opinions can provide insight into Invivyd's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Invivyd Stock analysis
When running Invivyd's price analysis, check to measure Invivyd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invivyd is operating at the current time. Most of Invivyd's value examination focuses on studying past and present price action to predict the probability of Invivyd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invivyd's price. Additionally, you may evaluate how the addition of Invivyd to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |